Alnylam Pharmaceuticals
ALNY
#378
Rank
A$91.11 B
Marketcap
A$689.70
Share price
-1.55%
Change (1 day)
76.66%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

Alnylam Pharmaceuticals (ALNY) Fails to deliver data

Key failure to deliver metrics for Alnylam Pharmaceuticals :

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Alnylam Pharmaceuticals (ALNY) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Alnylam Pharmaceuticals (ALNY) - since 2013

Volume in USD (price x number of shares), data since 2013

Alnylam Pharmaceuticals (ALNY) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2025A$35.09 M-18.73%
2024A$43.18 M-16.96%
2023A$51.99 M-66.55%
2022A$0.15 B200.46%
2021A$51.74 M-9.83%
2020A$57.38 M52.34%
2019A$37.66 M46.52%
2018A$25.7 M-70.97%
2017A$88.54 M191.96%
2016A$30.32 M-14.94%
2015A$35.65 M68.07%
2014A$21.21 M152.1%
2013A$8.41 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
Arrowhead Pharmaceuticals
ARWR
A$1.89 MA$7.19 M๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
A$5.36 MA$70.47 M๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
A$2.3 MA$22.38 M๐Ÿ‡บ๐Ÿ‡ธ USA
OPKO Health
OPK
A$0.07 MA$7.56 M๐Ÿ‡บ๐Ÿ‡ธ USA
Regulus Therapeutics
RGLS
N/AA$5.6 M๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$18.77 MA$0.12 B๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
A$4.1 MA$62.72 M๐Ÿ‡ซ๐Ÿ‡ท France
Teva Pharmaceutical Industries
TEVA
A$1.84 MA$36.3 M๐Ÿ‡ฎ๐Ÿ‡ฑ Israel